The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Ponstan 250 mg Capsules



Chemidex Pharma LimitedPA22643/001/001

Main Information

Trade NamePonstan 250 mg Capsules
Active SubstancesMefenamic acid
Dosage FormCapsule, hard
Licence HolderChemidex Pharma Limited
Licence NumberPA22643/001/001

Group Information

ATC CodeM01AG Fenamates
M01AG01 mefenamic acid

Status

License statusAuthorised
Licence Issued25/03/2004
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceNone
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back